查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1771588

mRNA合成原料市場規模、佔有率、趨勢分析報告：按類型、應用、最終用途、地區、細分市場預測，2025-2030年

mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report By Type (Capping Agents, Nucleotides, Plasmid DNA, Enzymes), By Application (Vaccine Production, Therapeutics Production), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

mRNA合成原料市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球mRNA合成原料市場規模預計到2030年將達到23億美元，2025年至2030年的複合年成長率為5.78%。

推動市場成長的關鍵因素包括學術界和工業界對 mRNA 技術的興趣日益濃厚、mRNA 疫苗佔據主導地位、研究資金不斷增加等。此外，預計 RNA 技術的治療應用日益增加將為預測期內的 mRNA 合成原料市場提供豐厚的機會。

新冠疫情 (COVID-19) 大流行增加了對 mRNA 合成原料的需求，用於高效開發疫苗以對抗感染疾病。 mRNA 疫苗是預防新冠疫情的安全有效方法。此外，mRNA 新冠疫苗的優勢激發了製藥公司在全球快速使用該疫苗的興趣。例如，美國國家過敏和感染疾病研究所 (NIAID) 和 Moderna 公司於 2020 年 3 月共同開發了 mRNA-1273（NIAID）。因此，在新冠疫情期間，mRNA 疫苗的使用量顯著增加。

此外，包括諾華、Alexion、阿斯特捷利康、輝瑞、賽諾菲巴斯德和Shire在內的多家大型製藥公司都已開始研發以mRNA為基礎的療法。例如，根據輝瑞與Accuitas Therapeutics於2022年1月達成的開發和選擇權協議，輝瑞將有權選擇將Accuitas的LNP技術授權給最多10個mRNA療法和疫苗開發標靶。因此，製藥和生物技術公司對mRNA合成原料的採用率正在不斷提高，這進一步推動了市場的成長。

此外，由於mRNA轉譯的瞬時性以及外源物質無法整合到細胞基因組中，因此所產生的細胞治療產品相比傳統方法具有許多優勢。這些優勢包括易於在可接受的製造程序下生產、降低因標靶脫靶效應引起的細胞毒性、改進臨床驗證和監管流程等。因此，這些優勢預計將增加對mRNA療法的需求，進一步推動市場成長。

此外，基於mRNA的技術已被證明在治療和預防多種疾病方面前景廣闊。過去十年，技術和科學研究的快速發展使mRNA成為一種可行的治療選擇，解決了其應用中的許多問題，例如其半衰期短和先天免疫抗原性。例如，mRNA技術的進步可能帶來更安全、更有效的方法，例如，結合新型過繼性免疫療法，可以產生尖端的嵌合體抗原受體T細胞。因此，預計mRNA技術的進步將為市場成長開闢新的途徑。

然而，在研究期間，原料的高成本可能會阻礙市場發展。例如，像 Cleancap AG 這樣的原料的採購價格約佔兩種疫苗生產過程中總原料成本的 45%。此外，核准流程的法律規範一直是生物技術、製藥和醫療技術產業最大的阻礙因素。在中國和印度等新興國家，mRNA 合成原料市場擁有巨大的成長潛力，但由於患者群體龐大，治療領域缺乏有效的法律規範和指導方針，預計將在未來幾年阻礙市場成長。

mRNA合成原料市場報告重點

  • 根據類型，由於封端技術的進步及其在生物製藥行業和研究中的應用，封端劑部分預計在預測期內以 6.42% 的最快複合年成長率成長。
  • 根據應用，疫苗製造領域在 2024 年佔據全球產業主導地位，收益佔有率最大。這是因為 mRNA 疫苗的生產速度比採用基於細胞培養的生產路線的傳統疫苗更快，而傳統疫苗往往容易失敗。
  • 預計北美將在 2024 年主導全球產業，佔 2023 年總收益的最大佔有率，超過 36.13%，並且預計在預測期內將以最高的複合年成長率成長。
  • 根據最終用途，生物製藥和製藥公司部門在 2023 年佔據了市場主導地位，收益佔有率最高，這得益於生物製藥的巨大商業性成功和治療藥物需求的快速成長。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章全球mRNA合成原料市場變數與趨勢

  • 市場展望
    • 母市場展望
    • 相關/輔助市場展望。
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • mRNA合成原料市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章 全球mRNA合成原料市場：類型評估與趨勢分析

  • 類型細分儀表板
  • 全球mRNA合成原料市場波動分析
  • 全球mRNA合成原料市場規模及趨勢分析（2018-2030年）
  • 封端劑
    • CleanCap試劑（TriLink BioTechnology）
    • ARCA（防反接電容模擬）
    • 其他
  • 核苷酸
    • 修飾核酸
    • 天然核酸
  • 質體DNA
  • 酵素
    • 聚合酵素
    • RNase抑制劑
    • DNase
  • 其他

第5章 全球mRNA合成原料市場：應用估算及趨勢分析

  • 應用程式細分儀表板
  • 全球mRNA合成原料市場使用變化分析
  • 全球mRNA合成原料市場規模及趨勢分析（依應用，2018-2030年）
  • 疫苗生產
  • 藥品製造
  • 其他

第6章全球mRNA合成原料市場：最終用途估計與趨勢分析

  • 最終用途細分儀表板
  • 全球mRNA合成原料市場最終用途變化分析
  • 全球mRNA合成原料市場規模及趨勢分析（依最終用途，2018-2030年）
  • 生物製藥和製藥公司
  • CRO 和 CMO
  • 學術研究所

第7章 mRNA 合成原料市場：區域估計與趨勢分析

  • 區域儀表板
  • 2018年至2030年市場規模、預測與趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024年企業市場分析
  • 公司簡介/上市公司
    • F. Hoffmann-La Roche Ltd.
    • Jena Bioscience Gmbh
    • Merck KGaA
    • Yeasen Biotechnology（Shanghai）Co.,Ltd.
    • BOC Sciences
    • Thermo Fisher Scientific, Inc.
    • Maravai Lifesciences
    • New England Biolabs
    • Creative Biogene
    • Hongene
Product Code: GVR-4-68040-022-4

mRNA Synthesis Raw Materials Market Growth & Trends:

The global mRNA synthesis raw materials market size is estimated to reach USD 2.30 billion by 2030, registering a CAGR of 5.78% from 2025 to 2030, according to a new report by Grand View Research, Inc. The major factors driving the market growth include growing academic and industrial interest in mRNA technology, the advantages of mRNA vaccines, and increasing funding for research. In addition, the increasing therapeutic applications of RNA technology are projected to offer lucrative opportunities for the mRNA synthesis raw materials market during the forecast period.

The COVID-19 pandemic has increased the demand for mRNA synthesis raw materials for developing an efficient vaccine to battle infectious diseases. mRNA vaccines are a safe and efficient method for preventing COVID-19. In addition, the advantages associated with the mRNA COVID-19 vaccines have sparked the attention of pharmaceutical businesses in delivering vaccines swiftly across the globe. For instance, the National Institute of Allergy and Infectious Diseases and Moderna, Inc. mutually developed the mRNA-1273 (NIAID) in March 2020. As a result, the usage of mRNA vaccines increased significantly during the COVID-19 pandemic.

Furthermore, many major pharmaceutical firms have started working on mRNA-based therapeutics, including Novartis, Alexion, AstraZeneca, Pfizer, Sanofi Pasteur, and Shire. For instance, in January 2022, according to a development and option agreement between Pfizer Inc. and Acuitas Therapeutics, Pfizer will have the option to license Acuitas' LNP technology for up to 10 targets for the development of mRNA therapeutics & vaccines. Therefore, the adoption rate of mRNA synthesis raw materials has increased among pharma & biotech companies, which further fuels the market growth.

Moreover, due to the temporary nature of mRNA translation and lack of integration of the foreign material into the cell's genome, the resulting cellular therapeutic product has a number of benefits over the one obtained by a more conventional approach. Some of the advantages include easier production under acceptable manufacturing procedures, reduced cytotoxicity from on-target off-tumor effects, and better clinical validation and regulatory treatment. Thus, such advantages are expected to increase the demand for mRNA therapeutics and further boost market growth.

Additionally, regarding the treatment and prevention of several diseases, mRNA-based technologies have been proven to be incredibly promising. Tremendous advances in technology and scientific study over the past ten years have made mRNA a feasible therapeutic option, eliminating some of the problems with its use, such as its brief half-life and innate immunogenicity. For instance, as mRNA technology advances, its fusion with new adoptive immunotherapies may result in safer and more efficient methods, such as the creation of cutting-edge chimeric antigen receptor T-cells. Therefore, advancements in mRNA technology are projected to open new avenues for market growth.

However, the high cost of raw materials may impede the market during the study period. For instance, the purchase price of raw materials, such as CleanCap AG, accounts for around 45% of the total raw material costs incurred while producing both vaccines. In addition, the regulatory framework pertaining to approval processes has always been the most critical restraining factor in the biotechnology, pharmaceutical, and medical technology industry. The absence of effective regulatory framework/guidelines for the therapeutic sector in developing countries such as China and India, where the mRNA synthesis raw materials market holds great growth potential due to the presence of a large patient base, is anticipated to impede the market growth in the coming years.

mRNA Synthesis Raw Materials Market Report Highlights:

  • By type, the capping agents segment is expected to grow with the fastest CAGR of 6.42% over the forecast period, owing to the advancements in the capping technology and their applications in the biopharma industry and research.
  • By application, the vaccine production segment dominated the global industry with the largest revenue share in 2024. This can be attributed to the rapid production of mRNA vaccines compared to the conventional vaccines that utilize cell-culture-based production paths, which are often prone to failure.
  • North America dominated the global industry in 2024 and accounted for the largest share of more than 36.13% of the overall revenue in 2023, and is expected to grow at the highest CAGR over the forecast period.
  • By end-use, the biopharmaceutical and pharmaceutical companies segment dominated the market with the highest revenue share in 2023, due to the high commercial success of biopharmaceuticals and rapid growth in demand for therapeutics.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Type Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Global mRNA Synthesis Raw Materials Market Variables & Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. mRNA Synthesis Raw Materials Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Global mRNA Synthesis Raw Materials Market: Type Estimates & Trend Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Global mRNA Synthesis Raw Materials Market Type Movement Analysis
  • 4.3. Global mRNA Synthesis Raw Materials Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Capping Agents
    • 4.4.1. Capping agents market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. CleanCap Reagents (TriLink BioTechnology)
      • 4.4.2.1. CleanCap reagents (TriLink BioTechnology) market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. ARCA (Anti-Reverse Cap Analog)
      • 4.4.3.1. ARCA (Anti-Reverse Cap Analog) market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Nucleotides
    • 4.5.1. Nucleotides market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Modified nucleic acids
      • 4.5.2.1. Modified nucleic acids market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.2. N1-methylpseudouridine-triphosphate
        • 4.5.2.2.1. N1-methylpseudouridine-triphosphate market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.3. 5-Methylcytidine triphosphate (5mCTP)
        • 4.5.2.3.1. 5-Methylcytidine triphosphate (5mCTP) market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.4. Others
        • 4.5.2.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Natural nucleic acids
      • 4.5.3.1. Natural nucleic acids market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.3.2. Adenine
        • 4.5.3.2.1. Adenine-triphosphate market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.3.3. Guanine
        • 4.5.3.3.1. Guanine market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.3.4. Cytosine
        • 4.5.3.4.1. Cytosine market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.3.5. Uracil
        • 4.5.3.5.1. Uracil market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Plasmid DNA
    • 4.6.1. Plasmid DNA market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Enzymes
    • 4.7.1. Enzymes market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.2. Polymerase
      • 4.7.2.1. Polymerase market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.3. RNase Inhibitor
      • 4.7.3.1. RNase inhibitor market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.4. DNase
      • 4.7.4.1. DNase market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Global mRNA Synthesis Raw Materials Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global mRNA Synthesis Raw Materials Market Application Movement Analysis
  • 5.3. Global mRNA Synthesis Raw Materials Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Vaccine Production
    • 5.4.1. Vaccine production market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Therapeutics Production
    • 5.5.1. Therapeutics production market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Global mRNA Synthesis Raw Materials Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Global mRNA Synthesis Raw Materials Market End Use Movement Analysis
  • 6.3. Global mRNA Synthesis Raw Materials Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Biopharmaceutical & Pharmaceutical Companies
    • 6.4.1. Biopharmaceutical & pharmaceutical companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. CROs & CMOs
    • 6.5.1. CROs & CMOs market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Academic & Research Institutes
    • 6.6.1. Academic & research institutes market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. MRNA Synthesis Raw Materials Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. North America MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. UK MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Germany MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Denmark MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Sweden MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Australia MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Thailand MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. South Korea MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Saudi Arabia MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. UAE MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait MRNA Synthesis Raw Materials Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. F. Hoffmann - La Roche Ltd.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Jena Bioscience Gmbh
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Merck KGaA
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Yeasen Biotechnology (Shanghai) Co.,Ltd.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. BOC Sciences
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Thermo Fisher Scientific, Inc.
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Maravai Lifesciences
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. New England Biolabs
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Creative Biogene
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Hongene
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 Global mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 5 Global mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 6 Global mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 7 Global mRNA synthesis raw materials Market, By Region, 2018 - 2030 (USD Million)
  • Table 8 North America mRNA synthesis raw materials Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 North America mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 11 North America mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 12 U.S. mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 U.S. mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 15 Canada mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 16 Canada mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 17 Canada mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 18 Mexico mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 19 Mexico mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 20 Mexico mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 21 Europe mRNA synthesis raw materials Market, By Country, 2018 - 2030 (USD Million)
  • Table 22 Europe mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 23 Europe mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 24 Europe mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 25 UK mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 26 UK mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 27 UK mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million),
  • Table 28 Germany mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 29 Germany mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 30 Germany mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 31 France mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 32 France mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 33 France mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 34 Spain mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 Spain mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 36 Spain mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 37 Italy mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 38 Italy mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 39 Italy mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 40 Denmark mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 41 Denmark mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 42 Denmark mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 43 Norway mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 44 Norway mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 45 Norway mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 46 Sweden mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 47 Sweden mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 48 Sweden mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific mRNA synthesis raw materials Market, By Country, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 53 China mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 54 China mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 55 China mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 56 Japan mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 57 Japan mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 58 Japan mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 59 India mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 60 India mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 61 India mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 62 South Korea mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 63 South Korea mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 64 South Korea mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 65 Australia mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 66 Australia mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 67 Australia mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 68 Thailand mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 69 Thailand mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 70 Thailand mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 71 Latin America mRNA synthesis raw materials Market, By Country, 2018 - 2030 (USD Million)
  • Table 72 Latin America mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 73 Latin America mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 74 Latin America mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million),
  • Table 75 Brazil mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 76 Brazil mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 77 Brazil mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 78 Argentina mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million),
  • Table 79 Argentina mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 80 Argentina mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 81 MEA mRNA synthesis raw materials Market, By Country, 2018 - 2030 (USD Million)
  • Table 82 MEA mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 83 MEA mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 84 MEA mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million),
  • Table 85 South Africa mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 86 South Africa mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 87 South Africa mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 88 UAE mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 UAE mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 90 UAE mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 91 Saudi Arabia mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million),
  • Table 92 Saudi Arabia mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 93 Saudi Arabia mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)
  • Table 94 Kuwait mRNA synthesis raw materials Market, By Type, 2018 - 2030 (USD Million)
  • Table 95 Kuwait mRNA synthesis raw materials Market, By Application, 2018 - 2030 (USD Million)
  • Table 96 Kuwait mRNA synthesis raw materials Market, By End-user, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 mRNA synthesis raw materials market segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Data analysis models
  • Fig. 4 Market formulation and validation
  • Fig. 5 Data validating & publishing
  • Fig. 6 Market research process
  • Fig. 7 Information procurement
  • Fig. 8 Primary research
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 mRNA synthesis raw materials market: Type outlook key takeaways
  • Fig. 13 mRNA synthesis raw materials market: Type movement analysis
  • Fig. 14 Global capping agents market, 2018 - 2030 (USD Million)
  • Fig. 15 Global cleancap reagents market, 2018 - 2030 (USD Million)
  • Fig. 16 Global ARCA (anti-reverse cap analog) market, 2018 - 2030 (USD Million)
  • Fig. 17 Global others market, 2018 - 2030 (USD Million)
  • Fig. 18 Global nucleotides market, 2018 - 2030 (USD Million)
  • Fig. 19 Global modified nucleic acid market, 2018 - 2030 (USD Million)
  • Fig. 20 Global N1-methylpseudouridine-triphosphate market, 2018 - 2030 (USD Million)
  • Fig. 21 Global 5-Methylcytidine triphosphate (5mCTP) market, 2018 - 2030 (USD Million)
  • Fig. 22 Global others market, 2018 - 2030 (USD Million)
  • Fig. 23 Global natural nucleic acids market, 2018 - 2030 (USD Million)
  • Fig. 24 Global adenine market, 2018 - 2030 (USD Million)
  • Fig. 25 Global guanine market, 2018 - 2030 (USD Million)
  • Fig. 26 Global cytosine market, 2018 - 2030 (USD Million)
  • Fig. 27 Global uracil market, 2018 - 2030 (USD Million)
  • Fig. 28 Global plasmid DNA market, 2018 - 2030 (USD Million)
  • Fig. 29 Global enzymes mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
  • Fig. 30 Global polymerase market, 2018 - 2030 (USD Million)
  • Fig. 31 Global RNase inhibitor market, 2018 - 2030 (USD Million)
  • Fig. 32 Global DNase market, 2018 - 2030 (USD Million)
  • Fig. 33 Global others market, 2018 - 2030 (USD Million)
  • Fig. 34 Global others mRNA synthesis raw materials market, 2018 - 2030 (USD Million)
  • Fig. 35 mRNA synthesis raw materials market: Application outlook and key takeaways
  • Fig. 36 mRNA synthesis raw materials market: Application movement analysis
  • Fig. 37 Global therapeutics production market, 2018 - 2030 (USD Million)
  • Fig. 38 Global vaccine production market, 2018 - 2030 (USD Million)
  • Fig. 39 Global other applications market, 2018 - 2030 (USD Million)
  • Fig. 40 mRNA synthesis raw materials market: End-user outlook and key takeaways
  • Fig. 41 mRNA synthesis raw materials market: End-user movement analysis
  • Fig. 42 Global biopharmaceutical & pharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 43 Global CROs & CMOs market, 2018 - 2030 (USD Million)
  • Fig. 44 Global academic & research institutes market, 2018 - 2030 (USD Million)
  • Fig. 45 Regional marketplace: Key takeaways
  • Fig. 46 North America mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 U.S. mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Canada mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Mexico mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Europe mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Germany mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 UK mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 France mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Italy mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Spain mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Market scenario
  • Fig. 66 Key country dynamics
  • Fig. 67 Denmark mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Regulatory framework
  • Fig. 69 Key country dynamics
  • Fig. 70 Norway mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Regulatory framework
  • Fig. 72 Key country dynamics
  • Fig. 73 Sweden mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Regulatory framework
  • Fig. 75 Asia Pacific mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Japan mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 China mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 India mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Australia mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Thailand mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 South Korea mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Latin America mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Brazil mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Argentina mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 MEA mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 South Africa mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Saudi Arabia mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 UAE mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 Kuwait mRNA synthesis raw materials market estimates and forecasts, 2018 - 2030 (USD Million)